Aligos Therapeutics, Inc. short interest in 2026
In 2026, Aligos Therapeutics, Inc.'s disclosed short interest ran from 1.71% of shares outstanding on 15 Jan 2026 to 5.59% on 15 Sep 2026, a change of +3.88 percentage points. The year's high was 5.59% on 15 Sep 2026 and its low 1.71% on 15 Jan 2026, averaging 3.59% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.35 days on 15 Sep 2026. Full history: Aligos Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 1.71% (15 Jan 2026)
- End of year
- 5.59% (15 Sep 2026)
- Change
- +3.88 pp
- High
- 5.59% (15 Sep 2026)
- Low
- 1.71% (15 Jan 2026)
- Average
- 3.59%
- Highest days to cover
- 15.35 (15 Sep 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 1.71% | 3.58 | |
| 30 Jan 2026 | 1.87% | 3.46 | |
| 13 Feb 2026 | 1.84% | 5.37 | |
| 27 Feb 2026 | 1.84% | 11.57 | |
| 13 Mar 2026 | 2.38% | 6.45 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 2.47% | 7.59 | |
| 15 Apr 2026 | 2.23% | 4.55 | |
| 30 Apr 2026 | 3.96% | 1.00 | |
| 15 May 2026 | 4.32% | 3.45 | 10-Q filed, results (8-K) |
| 29 May 2026 | 4.66% | 4.75 | |
| 15 Jun 2026 | 4.94% | 6.13 | |
| 30 Jun 2026 | 4.39% | 7.94 | |
| 15 Jul 2026 | 4.21% | 1.01 | |
| 31 Jul 2026 | 4.90% | 6.39 | |
| 14 Aug 2026 | 4.55% | 2.71 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 5.19% | 9.41 | |
| 15 Sep 2026 | 5.59% | 15.35 |
See also: Aligos Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.